{
  "Question": "K-BioCELF Inc. CES 2024 product highlight and specification",
  "Summary": "K-BioCELF Inc.\n\nCES 2024\n\n- Develops liquid biopsy platform for early cancer detection and prevention\n- Offers CELB ACE + ONT system for liquid biopsy platform technology\n- Utilizes circulating tumor cell (CTC) separation device technology for selecting living cancer cells\n- Provides personalized platform based on automated cell culture and sample separation and automation system\n- Offers other products and services including CELP, CELF, CELH, and customer automation system\n- Focuses on diagnostic equipment, advanced biopharmaceuticals, autoimmune disease treatment, anticancer treatment, and bio-production automation equipment"
}